文献速递血栓与止血

抗核抗体滴度及其变化对儿童原发免疫性血小板减少症结局的影响

The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopenia.
PubMed 文献 · Br J Haematol · 2023-03-17

该单中心回顾性队列研究纳入中国北京协和医院324例原发免疫性血小板减少症(ITP)患儿,中位随访25个月,39.2%患儿抗核抗体(ANA)滴度≥1:160。广义估计方程显示ANA滴度较高者起病时血小板计数较低但后续血小板恢复率较高;Cox回归显示ANA滴度≥1:160者更易进展为自身免疫性疾病(AID),且风险随滴度升高而增加(趋势P<0.001)。

要点

  • 324例原发ITP患儿中39.2%抗核抗体滴度≥1:160。
  • ANA滴度较高者起病时血小板计数较低,但后续血小板恢复率较高。
  • ANA滴度≥1:160者进展为自身免疫性疾病风险更高,且随滴度升高而增加。

核心结论

  • 数据凸显ANA滴度对儿童原发ITP血小板计数及自身免疫性疾病发生风险的预测价值。

研究设计与样本

  • 单中心回顾性队列研究,纳入中国北京协和医院324例原发ITP患儿,中位随访25个月。

主要发现

  • 39.2%患儿ANA滴度≥1:160。
  • 广义估计方程模型显示ANA滴度较高者起病时血小板计数较低但后续血小板计数恢复率较高。
  • 校正潜在混杂因素的Cox回归模型显示ANA滴度≥1:160者较无此滴度者更易进展为自身免疫性疾病,且风险随ANA滴度升高而增加(趋势P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antinuclear antibody (ANA) can be positive in children with primary immune thrombocytopenia (ITP), but the effect of ANA titre and its variation on outcomes of children with primary ITP remains unclear. Here, we conducted a single-centre retrospective cohort study of children with primary ITP at the Peking Union Medical College Hospital in China. A total of 324 children with primary ITP included in this study were followed for a median time of 25 months. In this cohort, 39.2% had an ANA titre of 1:160 or higher. Results from a generalized estimating equation model revealed that patients with higher ANA titres had lower platelet counts at onset but a higher recovery rate of subsequent platelet counts. Results from Cox regression models adjusted for potential confounders revealed that patients with ANA titres of 1:160 or more were more likely to develop to autoimmune disease (AID) than those without, and the risk of AID development increased with the rise of ANA titres (p value for trend less than 0.001). These data highlight the predictive value of ANA titre for platelet counts and the risk of AID development in children with primary ITP.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Liu J, Zhang Y, Li Z, et al. The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopenia. Br J Haematol. 2023. PMID: 36929463. doi:10.1111/bjh.18732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。